Perioperative CapeOx therapy for clinical stage III gastric cancer; a phase II study (OGSG1601)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 May 2017
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 May 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Oct 2016 Status changed from not yet recruiting to recruiting.
- 25 May 2016 New trial record